Changes are on the cards for some breast cancer patients.
Pharmac is consulting on a drug switch proposal to replace the current expired one.
Herzuma is said to be more safe and cost effective, but at what there are concerns about whether all patients will be suited to it.
Breast Cancer Foundation's Research and Strategics Manager, Adele Gautier, joined Kate Hawkesby.
LISTEN ABOVE

Kevin Putt: Former Springbok previews the final Greatest Rivalry test between the All Blacks and Springboks
02:18

Leon Panetta: Former Defence Secretary and CIA Director on the US-Iran war
08:17

Graeme Edgeler: Constitutional law expert on an MSD review which found more than 30-thousand cases, where benefits and payments were wrongly suspended
04:04